Publicaciones - Metalofármacos antitumorales no convencionales

Cargando...

Linero-Artiaga A., Svitelova M., Novohradský V., Rodríguez V., Markova L., Kasparkova J., Janiak C., Ruiz J., Brabec V. Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance. Journal of Medicinal Chemistry. 26 March 2026. 69:6991-7011. 10.1021/acs.jmedchem.5c03280

AÑO: 2026; IF: 7.3

41837869

Ashoo P., Hernández-García A., Izquierdo-García E., Santiago N., Mondaray-Marín R., Abad-Montero D., Bosch M., Isidro N., Novikov V.V., Rocas J., Santana M.D., Ruiz J., Marchán V. Novel Heteroleptic Iridium(III) Complexes Containing COUBPY Ligands for Effective Photoinduction of Ferroptosis for Cancer Therapy. Jacs Au. 23 March 2026. 6:1585-1601. 10.1021/jacsau.5c01441

AÑO: 2026; IF: 8.5

Romero-Castellón I., Markova L., Piernas-Muñoz M.J., Kostrhunova H., Kasparkova J., Janiak C., Alberto M.E., Francés-Monerris A., Ruiz J., Brabec V. Photocatalytic arylterpyridine iridium(iii) complexes trigger oncosis in 2D and 3D cancer cell models via NADH oxidation. Inorganic Chemistry Frontiers. 3 March 2026. 13:2045-2063. 10.1039/d5qi02205c

AÑO: 2026; IF: 6.4

Linero-Artiaga A., Montesdeoca N., Papadopoulos Z., Siekierski P., Rodríguez V., Ruiz J., Karges J. Encapsulation of a Cyclometalated Iridium(III) Photosensitizer into Nanosized Micelles for Oncosis-Inducing Photodynamic Therapy. ACS Applied Nano Materials. 13 February 2026. 9:2924-2934. 10.1021/acsanm.5c05384

AÑO: 2026; IF: 5.8

Vigueras G., Marchán V., Ruiz J. Insights into type I photoreactivity of cyclometalated iridium(iii) and ruthenium(ii) photosensitizers. Chemical Communications. 4 December 2025. 61:18302-18314. 10.1039/d5cc05162b

AÑO: 2025; IF: 4.3

41170623

Siguiente >

Publicaciones - Metalofármacos antitumorales no convencionales

Instituto de Investigación Sanitaria Acreditado

Metalofármacos antitumorales no convencionales